BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/17/2026 2:05:34 AM | Browse: 1 | Download: 0
Publication Name World Journal of Clinical Oncology
Manuscript ID 126700
Country Italy
Received
2026-08-11 03:05
Peer-Review Started
2026-08-11 03:06
First Decision by Editorial Office Director
Return for Revision
2026-08-24 03:08
Revised
2026-08-28 16:59
Publication Fee Transferred
Editorial Processing by Scientific Editor
2026-11-02 02:18
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director
2026-11-02 02:44
Articles in Press
2026-11-02 02:44
Edit the Manuscript by Language Editor
Typeset the Manuscript
2026-11-10 02:12
Publish the Manuscript Online
2026-11-17 02:05
ISSN 2218-4333 (online)
Open Access This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Copyright ©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Surgery
Manuscript Type Minireviews
Article Title Specific molecular signature redefines the role of posterior and para-aortic (D2 plus) lymphadenectomy in gastric cancer: Rethinking surgical indications
Manuscript Source Invited Manuscript
All Author List Ludovico Carbone, Daniele Marrelli, Bina Barbato, Aurora Visani, Giovanni Corso and Franco Roviello
ORCID
Author(s) ORCID Number
Ludovico Carbone http://orcid.org/0000-0003-2862-6788
Daniele Marrelli http://orcid.org/0000-0003-2066-1618
Aurora Visani http://orcid.org/0009-0002-8832-9953
Giovanni Corso http://orcid.org/0000-0002-9269-0146
Franco Roviello http://orcid.org/0000-0003-4122-1259
Funding Agency and Grant Number
Corresponding Author Daniele Marrelli, MD, Department of Medicine Surgery and Neuroscience, University of Siena, viale Mario Bracci 11, Siena 53100, Tuscany, Italy. daniele.marrelli@unisi.it
Key Words Stomach cancer; Multimodality approach; Lymph node excision; Translational research; Mismatch repair deficiency; Complications; Robot surgery
Core Tip D2 plus lymphadenectomy in gastric cancer should be tailored to tumor biology and treatment response. Pathological response to neoadjuvant therapy is the strongest prognostic factor, whereas the emerging molecular characterization (microsatellite instable, programmed cell death ligand 1, epithelial-mesenchymal transition, or human epidermal growth factor receptor 2 status) predicts nodal spread pattern and tumors which likely benefit from extended nodal dissection. In selected oligometastatic patients, para-aortic lymphadenectomy can be integrated into a conversion surgery strategy to achieve complete radicality. Molecular profiling, therefore, represents a promising tool to refine treatment course and surgical indications for lymphadenectomy beyond tumor node metastasis staging alone.
Publish Date 2026-11-17 02:05
Citation

Carbone L, Marrelli D, Barbato B, Visani A, Corso G, Roviello F. Specific molecular signature redefines the role of posterior and para-aortic (D2 plus) lymphadenectomy in gastric cancer: Rethinking surgical indications. World J Clin Oncol 2026; 17(11): 126700

URL https://www.wjgnet.com/2218-4333/full/v17/i11/126700.htm
DOI https://doi.org/10.5306/wjco.126700
Full Article (PDF) WJCO-17-126700-with-cover.pdf